Company intelligence / Profile preview

adMare BioInnovations

Ownership: Private
Employees: ~132
Development stage: Other

Overview

adMare does not directly run clinical trials but has enabled the creation and growth of several successful Canadian biotech companies that have advanced programs into clinical stages. It provides expertise, infrastructure, capital, and network support to move academic discoveries toward commercialization. Companies supported include Zymeworks, Bellus Health, Inversago Pharma among others. No direct clinical results are attributed to "adMare" as an entity.

Therapeutic areas: Other
Modalities: Small moleculesPeptidesBiologics (including antibodies)Antibody-drug conjugates (ADCs)Platform technologies (various)
Industry: Investors

Partnerships

Collaborates with Canadian universities/research institutesPartners with venture capitalists and technology transfer offices across Canada

Beyond the preview

Go deeper on adMare BioInnovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on adMare BioInnovations.

Explore the full profile